Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Nephrology · Atherosclerotic Renal Artery Stenosis

Living Well: Your Long-Term Management Plan

At a Glance

Long-term care for renal artery atheroma focuses on controlling blood pressure, taking medicines consistently, protecting kidney function with regular blood and urine tests, and following an ultrasound schedule if you have a stent.

Living with renal artery atheroma (ARAS) means shifting your focus from “fixing” a blockage to “managing” a lifelong vascular condition. While the diagnosis can feel heavy, the majority of people live full, active lives by adhering to a steady routine of monitoring and medical care [1]. Your “new normal” is built on three foundations: tracking your numbers, maintaining your medications, and knowing when to alert your care team.

The Surveillance Schedule

There is no “one-size-fits-all” calendar for monitoring ARAS. Your schedule will be individualized based on your kidney function stage, potassium levels, medication changes, and whether you have received a stent.

For Medical Management

If you are treating ARAS with medications, surveillance is usually “clinically driven.” This means you won’t necessarily need a scan every few months. Instead, your doctor will monitor your body’s response [2]:

  • Blood Work: You will need regular tests for creatinine and eGFR (to check kidney function) and potassium (which can be affected by blood pressure drugs) [3]. These are often checked within 1–2 weeks of any medication change and then periodically (such as every 6–12 months) once you are stable [3][4].
  • Urine Tests: Checking for albuminuria (protein in the urine) is a key way to monitor kidney health over time [5].
  • Imaging: Repeat ultrasounds are typically only ordered if your blood pressure suddenly becomes harder to control, your kidney function starts to decline, or you develop new symptoms [6].

For Patients with a Stent

If you have a stent, monitoring is more structured to ensure the artery stays open (a process called checking for patency) [7]:

  • Initial Follow-up: You will likely have a “baseline” ultrasound and lab check about 1 month after the procedure [8].
  • Ongoing Scans: Many specialists recommend a follow-up Duplex ultrasound at 6 months, 12 months, and then annually to watch for restenosis (the artery narrowing again inside the stent) [9][10].

Mastering Home Blood Pressure Monitoring

Your home blood pressure log is the most valuable tool your doctor has. To get accurate readings:

  1. Use the Right Equipment: Use a validated, automatic upper-arm cuff, ensuring it is the correct size for your arm. Wrist monitors are generally less accurate [11].
  2. The “5-Minute Rule”: Sit quietly in a chair with your back supported, your arm supported at heart level, and feet flat on the floor for 5 minutes before taking a reading. Do not talk or use your phone. Avoid caffeine, exercise, and smoking right beforehand.
  3. The Schedule: Average your readings over several days. For the week before your doctor’s appointment (or after a medication change), take two readings in the morning and two in the evening [10].
  4. The Goal: While targets are individualized, many guidelines aim for a consistent home reading below 130/80 mmHg [12][13].

Daily Habits for Kidney Protection

  • The “Salt Sensitivity” Factor: High salt intake forces your kidneys to work harder and raises blood pressure. Aim for a “heart-healthy” diet, which typically limits sodium to less than 2,300 mg per day, though your doctor may recommend even less [14][4].
  • Medication Adherence: Repeated missed doses of your blood pressure medication can worsen your control and put strain on your heart and kidneys. If you miss a dose, ask your pharmacist for advice on what to do; do not double up unless instructed [2].
  • Avoid NSAIDs: Common over-the-counter pain relievers like ibuprofen or naproxen can reduce blood flow to the kidneys and should be avoided or used only under strict medical supervision. They are especially risky if you have kidney disease, are dehydrated, or take an ACE inhibitor [15].

Long-Term Outlook

It is common to experience “scan anxiety” before an ultrasound or blood test. However, keep in mind that with modern medical therapy, fewer than 8% of stable trial patients with ARAS progressed to the point of needing dialysis [16]. By managing your blood pressure and cholesterol today, you are not just protecting your kidneys; you are significantly lowering your risk of heart attack and stroke, ensuring a better quality of life for years to come [4][17].

Common questions in this guide

How often should kidney blood tests be checked with renal artery atheroma?
Creatinine, eGFR, and potassium are often checked within 1–2 weeks after a blood pressure medicine is changed. If results are stable, testing may be repeated every 6–12 months, but your clinician should set the schedule based on your kidney function, potassium level, and treatment.
What follow-up is needed after a renal artery stent?
Many patients have a baseline ultrasound and lab check about one month after the procedure, followed by duplex ultrasounds around 6 months, 12 months, and yearly. The exact schedule depends on your specialist and your test results.
How can I get accurate blood pressure readings at home?
Use a validated automatic upper-arm cuff that fits properly. Sit quietly for five minutes with your back supported, feet flat, and arm at heart level, then take two readings in the morning and evening for several days when preparing for an appointment or after a medicine change.
Should I change my diet or avoid pain relievers to protect my kidneys?
A heart-healthy diet often limits sodium to less than 2,300 mg a day, although your clinician may recommend a lower amount. Ibuprofen and naproxen can reduce kidney blood flow, so avoid them or use them only with medical guidance, especially if you have kidney disease, dehydration, or take an ACE inhibitor.
Do I need regular scans if I am managing renal artery atheroma without a stent?
Not always. Imaging is usually considered when blood pressure becomes harder to control, kidney function declines, or new symptoms develop; your clinician will individualize the plan.
What is the long-term outlook for people with renal artery atheroma?
In stable patients treated with modern medical therapy, fewer than 8% progressed to needing dialysis in the cited trial population, although individual outlooks vary. Controlling blood pressure and cholesterol also helps lower the risk of heart attack and stroke.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific blood pressure target should I be aiming for at home?
  2. 2.How often should we repeat my kidney function tests (creatinine and potassium)?
  3. 3.If I have a stent, how frequently do you recommend follow-up ultrasounds to check for narrowing (restenosis)?
  4. 4.Should I be checking my urine for protein, and if so, how often?
  5. 5.Are there specific types of over-the-counter medications, like certain pain relievers, that I must avoid to protect my kidneys?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Quality of life effects of renal artery stenting versus medical therapy for atherosclerotic renal-artery stenosis: results from the randomized CORAL trial.

    Arnold SV, Wang K, Kirtane AJ, et al.

    European heart journal. Quality of care & clinical outcomes 2025; (11(8)):1388-1395 doi:10.1093/ehjqcco/qcae087.

    PMID: 39402005
  2. 2

    Revascularization of atherosclerotic renal artery stenosis in patients with heart failure.

    Green D, Cleland JGF, Pellicori P, et al.

    European journal of heart failure 2026; doi:10.1093/ejhf/xuag042.

    PMID: 41771107
  3. 3

    Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy.

    Rivoli L, Di Mario F, Coppolino G, et al.

    Current drug metabolism 2016; (17(6)):550-8 doi:10.2174/1389200217666160219114443.

    PMID: 26892730
  4. 4

    Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.

    Tuttle KR, Dworkin LD, Henrich W, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2016; (11(7)):1180-1188 doi:10.2215/CJN.10491015.

    PMID: 27225988
  5. 5

    Incident Heart Failure in Atherosclerotic Renal Artery Stenosis: A Post Hoc Analysis of the CORAL Trial.

    Gupta R, Estrella MM, Scherzer R, et al.

    Kidney medicine 2025; (7(2)):100948 doi:10.1016/j.xkme.2024.100948.

    PMID: 39895851
  6. 6

    Renovascular Disease and Mesenteric Vascular Disease.

    Sharma S, Henkin S, Young MN

    Cardiology clinics 2021; (39(4)):527-537 doi:10.1016/j.ccl.2021.06.005.

    PMID: 34686265
  7. 7

    Renal Artery Stenosis: When to Revascularize in 2017.

    Tafur JD, White CJ

    Current problems in cardiology 2017; (42(4)):110-135 doi:10.1016/j.cpcardiol.2017.01.004.

    PMID: 28325353
  8. 8

    Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia.

    Gavalas MV, Gasparis AP, Tassiopoulos AK, et al.

    International angiology : a journal of the International Union of Angiology 2015; (34(6)):529-37.

    PMID: 24824840
  9. 9

    A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study.

    Zeller T, Krankenberg H, Erglis A, et al.

    Trials 2017; (18(1)):380 doi:10.1186/s13063-017-2126-x.

    PMID: 28807045
  10. 10

    Renal Artery Stenting in Consecutive High-Risk Patients With Atherosclerotic Renovascular Disease: A Prospective 2-Center Cohort Study.

    Reinhard M, Schousboe K, Andersen UB, et al.

    Journal of the American Heart Association 2022; (11(7)):e024421 doi:10.1161/JAHA.121.024421.

    PMID: 35322677
  11. 11

    The efficacy of renal artery stent combined with optimal medical therapy in patients with severe atherosclerotic renal artery stenosis.

    Jiang X, Peng M, Li B, et al.

    Current medical research and opinion 2016; (32(sup2)):3-7 doi:10.1080/03007995.2016.1218833.

    PMID: 27779455
  12. 12

    Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi-disciplinary review.

    de Bhailis ÁM, Lake E, Chrysochou C, et al.

    Journal of nephrology 2024; (37(4)):1093-1105 doi:10.1007/s40620-024-01902-1.

    PMID: 38594599
  13. 13

    Comparative Effectiveness of Management Strategies for Renal Artery Stenosis: An Updated Systematic Review.

    Raman G, Adam GP, Halladay CW, et al.

    Annals of internal medicine 2016; (165(9)):635-649 doi:10.7326/M16-1053.

    PMID: 27536808
  14. 14

    Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH).

    Sarafidis PA, Theodorakopoulou M, Ortiz A, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2023; (38(12)):2835-2850 doi:10.1093/ndt/gfad095.

    PMID: 37202218
  15. 15

    Percutaneous transluminal renal artery stenting using digital subtraction angiography with diluted contrast medium in a patient with severe chronic kidney disease.

    Oyama Y, Koiwa S, Maruyama T, et al.

    Journal of cardiology cases 2022; (26(5)):317-320 doi:10.1016/j.jccase.2022.06.002.

    PMID: 36312781
  16. 16

    Progress in the treatment of atherosclerotic renovascular disease: the conceptual journey and the unanswered questions.

    Vassallo D, Kalra PA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016; (31(10)):1595-605 doi:10.1093/ndt/gfv278.

    PMID: 26187997
  17. 17

    Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions).

    Murphy TP, Cooper CJ, Pencina KM, et al.

    Hypertension (Dallas, Tex. : 1979) 2016; (68(5)):1145-1152 doi:10.1161/HYPERTENSIONAHA.116.07744.

    PMID: 27647847

This page is for informational purposes only and does not constitute medical advice. Your clinician should personalize your blood pressure goals, testing schedule, medicines, and stent follow-up.

Get notified when new evidence is published on renal artery atheroma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.